Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Nov-21 9:04 AM View:  | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 18,509 | -- | -- | (100%) 18.51K to 0 | |
| 27-Sep-21 7:21 PM View: | Acceleron Pharma Inc (XLRN) | 27-Sep-21 | Option Exercise | 5,000 | $40.61 | $203,050.00 | 27% 18.51K to 23.51K | |
| 27-Sep-21 7:21 PM View: | Acceleron Pharma Inc (XLRN) | 27-Sep-21 | Market Option Sale (Planned) | 5,000 | $175.00 | $875,000.00 | (21%) 23.51K to 18.51K | (3%) |
| 22-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 21-Sep-21 | Option Exercise | 5,000 | $40.61 | $203,050.00 | 27% 18.51K to 23.51K | |
| 22-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 21-Sep-21 | Market Option Sale (Planned) | 5,000 | $150.03 | $750,150.00 | (21%) 23.51K to 18.51K | (20%) |
| 04-Mar-21 5:17 PM View: | Acceleron Pharma Inc (XLRN) | 02-Mar-21 | Option Exercise | 5,000 | $40.61 | $203,050.00 | 26% 19.4K to 24.4K | |
| 04-Mar-21 5:17 PM View: | Acceleron Pharma Inc (XLRN) | 02-Mar-21 | Market Option Sale (Planned) | 5,000 | $136.01 | $680,059.00 | (20%) 24.4K to 19.4K | (32%) |
| 08-Jun-21 6:48 PM View: | Acceleron Pharma Inc (XLRN) | 12-Feb-21 | Payment of Exercise | 887 | $130.87 | $116,082.00 | (5%) 19.4K to 18.51K | (37%) |
| 02-Feb-21 7:42 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 5,409 | -- | -- | 39% 13.99K to 19.4K | |
| 06-Jan-21 7:09 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-21 | Payment of Exercise | 1,357 | $124.31 | $168,689.00 | (9%) 15.34K to 13.99K | (45%) |
| 06-Jan-21 7:09 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-21 | Market Sale (Planned) | 10,000 | $125.38 | $1,253,760.00 | (71%) 13.99K to 3.99K | (43%) |
| 14-Feb-20 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 13-Feb-20 | Market Sale (Planned) | 595 | $94.10 | $55,987.20 | (4%) 15.94K to 15.34K | (91%) |
| 24-Jan-20 5:27 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 6,369 | -- | -- | 67% 9.57K to 15.94K | |
| 03-Jan-20 9:48 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-20 | Market Sale (Planned) | 480 | $51.37 | $24,656.50 | (5%) 10.05K to 9.57K | (250%) |
| 29-Jan-19 5:42 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 4,050 | -- | -- | 68% 6.0K to 10.05K | |
| 13-Feb-18 5:50 PM View: | Acceleron Pharma Inc (XLRN) | 12-Feb-18 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 14-Dec-16 5:16 PM View: | Infinity Pharmaceuticals, I... (INFI) | 13-Dec-16 | Market Sale | 49,991 | $1.27 | $63,258.90 | (92%) 54.19K to 4.2K | (68%) |
| 14-Dec-16 5:16 PM View: | Infinity Pharmaceuticals, I... (INFI) | 12-Dec-16 | Market Sale | 25,009 | $1.30 | $32,611.70 | (32%) 79.2K to 54.19K | (63%) |
| 02-Nov-16 4:56 PM View: | Infinity Pharmaceuticals, I... (INFI) | 31-Oct-16 | Grant | 75,000 | -- | -- | 1787% 4.2K to 79.2K |